K. J. Schjoedt

Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy

Kasper Rossing, K. J. Schjoedt, U. Smidt et al. · Diabetes Care · 2005 · 293 citations · Full text

Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate

K. J. Schjoedt, Steen Andersen, Peter Rossing et al. · Diabetologia · 2004 · 236 citations · Full text

Aldosterone Escape, Hypertension, Renal Function +9

Beneficial impact of spironolactone in diabetic nephropathy

K. J. Schjoedt, Kasper Rossing, Tina R. Juhl et al. · Kidney International · 2005 · 235 citations · Full text

Medicine, Diabetes, Pharmacology +5

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

Kasper Rossing, K. J. Schjoedt, Berit R. Jensen et al. · Kidney International · 2005 · 226 citations

Renal Function, Chronic Kidney Disease, Pharmacology +8

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy

K. J. Schjoedt, Kasper Rossing, Tina R. Juhl et al. · Kidney International · 2006 · 211 citations

Glomerulonephritis, Renal Function, Renal Disease +12